JUNS
Jupiter Neurosciences, Inc.
Price Chart
Latest Quote
$0.24
-0.02 (-6.48%)
Current Price
| Previous Close | $0.25 |
| Open | $0.24 |
| Day High | $0.25 |
| Day Low | $0.22 |
| Volume | 3,941,930 |
Stock Information
| Shares Outstanding | 48.22M |
| Total Debt | $4.83M |
| Cash Equivalents | $2.36M |
| Revenue | $40K |
| Net Income | $-9.18M |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market Cap | $11.41M |
| EPS (TTM) | $-0.26 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $11.05M |
| Sales | $40K |
| Income | $-9.18M |
| Book/sh | $-0.08 |
| Cash/sh | $0.05 |
| Employees | 5 |
Financial Ratios
| Quick Ratio | 0.35 |
| Current Ratio | 0.51 |
Returns & Margins
| ROA | -130.92% |
| ROE | -6529.17% |
| Operating Margin | -10524.34% |
Ownership
| Insider Ownership | 37.91% |
| Institutional Ownership | 3.95% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 3.94 |
| P/S | 282.09 |
| P/B | -3.07 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $0.24 |
| SMA50 | $0.31 |
| SMA200 | $0.83 |
| RSI | 41.82 |
| ATR | 0.0202 |
| Shares Float | 22.50M |
| Short Float | 0.49% |
| Short Ratio | 0.01 |
| Rel Volume | 1.18 |
Performance History
| Week | +3.04% |
| Month | +3.04% |
| Quarter | -32.48% |
| 6 Months | -78.45% |
| YTD | -76.53% |
| Year | -79.03% |
| 10 Years | -95.68% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-25 | $0.24 | 4,138,400 |
| 2026-06-24 | $0.25 | 12,621,000 |
| 2026-06-23 | $0.24 | 5,309,100 |
| 2026-06-22 | $0.23 | 943,400 |
| 2026-06-18 | $0.24 | 938,200 |
| 2026-06-17 | $0.23 | 1,823,100 |
| 2026-06-16 | $0.23 | 1,430,100 |
| 2026-06-15 | $0.24 | 2,025,300 |
| 2026-06-12 | $0.24 | 1,750,200 |
| 2026-06-11 | $0.23 | 2,117,900 |
| 2026-06-10 | $0.22 | 2,003,500 |
| 2026-06-09 | $0.23 | 1,579,400 |
| 2026-06-08 | $0.23 | 1,916,000 |
| 2026-06-05 | $0.24 | 2,554,500 |
| 2026-06-04 | $0.25 | 2,965,700 |
| 2026-06-03 | $0.25 | 2,337,400 |
| 2026-06-02 | $0.28 | 4,426,800 |
| 2026-06-01 | $0.26 | 4,586,900 |
| 2026-05-29 | $0.26 | 4,826,800 |
| 2026-05-28 | $0.29 | 9,811,100 |
| 2026-05-27 | $0.24 | 9,154,100 |
| 2026-05-26 | $0.23 | 6,213,000 |
About Jupiter Neurosciences, Inc.
Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, engages in the development of therapeutics for central nervous system disorders and rare diseases in the United States and internationally. It operates in two segments, Pharmaceutical Operations and Premium Nutritional Supplements. The company researches and develops JNS115, which is in Phase IIa clinical trial for the treatment of Parkinson's disease; JNS108, which is in Phase II clinical trial for the treatment of mild cognitive impairment/early Alzheimer's disease; JNS102, which is in Phase II clinical trial for the treatment of mucopolysaccharidosis type 1; and JNS107, which is in Phase II clinical trial for the treatment of mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes syndrome. It is also involved in the commercialization and sale of GLO for skin beauty, MND for mental clarity, and PWR for energy, endurance, and muscle recovery under the Nugevia brand name. The company was formerly known as Jupiter Orphan Therapeutics, Inc. and changed its name to Jupiter Neurosciences, Inc. in August 2021. Jupiter Neurosciences, Inc. was incorporated in 2016 and is headquartered in Jupiter, Florida.
đ° Latest News
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $4,231 | - | - | - |
| Cost Of Revenue | $4,231 | - | - | - |
| Total Revenue | $21,796 | $0 | $0 | $233,281 |
| Operating Revenue | $21,796 | $0 | $0 | $233,281 |
| Expenses | ||||
| Interest Expense | $66,020 | $248,366 | $218,705 | $740,854 |
| Total Expenses | $8,930,517 | $3,091,282 | $3,870,771 | $3,665,728 |
| Other Income Expense | $329,844 | $894,466 | $-694,695 | $-784,896 |
| Other Non Operating Income Expenses | $329,844 | $90,000 | $44,500 | - |
| Net Non Operating Interest Income Expense | $-66,020 | $-242,809 | $-218,223 | $-740,237 |
| Interest Expense Non Operating | $66,020 | $248,366 | $218,705 | $740,854 |
| Operating Expense | $8,926,286 | $3,091,282 | $3,870,771 | $3,665,728 |
| General And Administrative Expense | $6,839,712 | $2,598,622 | $2,915,978 | $2,722,922 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-8,644,897 | $-2,439,625 | $-4,783,689 | $-4,957,580 |
| Net Interest Income | $-66,020 | $-242,809 | $-218,223 | $-740,237 |
| Interest Income | $0 | $5,557 | $482 | $617 |
| Normalized Income | $-8,644,897 | $-3,244,091 | $-4,044,494 | $-4,172,684 |
| Net Income From Continuing And Discontinued Operation | $-8,644,897 | $-2,439,625 | $-4,783,689 | $-4,957,580 |
| Total Operating Income As Reported | $-8,908,721 | $-3,091,282 | $-3,870,771 | $-3,432,447 |
| Net Income Common Stockholders | $-8,644,897 | $-2,439,625 | $-4,783,689 | $-4,957,580 |
| Net Income | $-8,644,897 | $-2,439,625 | $-4,783,689 | $-4,957,580 |
| Net Income Including Noncontrolling Interests | $-8,644,897 | $-2,439,625 | $-4,783,689 | $-4,957,580 |
| Net Income Continuous Operations | $-8,644,897 | $-2,439,625 | $-4,783,689 | $-4,957,580 |
| Pretax Income | $-8,644,897 | $-2,439,625 | $-4,783,689 | $-4,957,580 |
| Special Income Charges | $0 | $857,723 | $-887,946 | $-1,047,410 |
| Interest Income Non Operating | $0 | $5,557 | $482 | $617 |
| Operating Income | $-8,908,721 | $-3,091,282 | $-3,870,771 | $-3,432,447 |
| Gross Profit | $17,565 | - | - | - |
| Per Share | ||||
| Diluted EPS | $-0.25 | $-0.08 | $-0.18 | $-0.15 |
| Basic EPS | $-0.25 | $-0.08 | $-0.18 | $-0.15 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-8,578,877 | $-2,995,725 | $-3,825,789 | $-3,431,830 |
| Total Unusual Items | $0 | $804,466 | $-739,195 | $-784,896 |
| Total Unusual Items Excluding Goodwill | $0 | $804,466 | $-739,195 | $-784,896 |
| EBITDA (Bullshit earnings) | $-8,578,877 | $-2,191,259 | $-4,564,984 | $-4,216,726 |
| EBIT | $-8,578,877 | $-2,191,259 | $-4,564,984 | $-4,216,726 |
| Diluted Average Shares | $34,628,588 | $28,783,045 | $26,405,109 | $32,876,413 |
| Basic Average Shares | $34,628,588 | $28,783,045 | $26,405,109 | $32,876,413 |
| Diluted NI Availto Com Stockholders | $-8,644,897 | $-2,439,625 | $-4,783,689 | $-4,957,580 |
| Research And Development | $2,086,574 | $492,660 | $954,793 | $942,806 |
| Selling General And Administration | $6,839,712 | $2,598,622 | $2,915,978 | $2,722,922 |
| Other Gand A | $6,839,712 | $2,598,622 | $2,915,978 | $2,722,922 |
| Other Special Charges | - | $-857,723 | $887,946 | $1,047,410 |
| Gain On Sale Of Security | - | $-53,257 | $148,751 | $262,514 |
Fetched: 2026-06-23
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $-1,831,852 | $4,172,008 | $-5,801,354 | $-7,144,084 |
| Total Assets | $5,564,030 | $6,202,409 | $148,592 | $235,944 |
| Total Non Current Assets | $739,052 | $1,552,146 | $119,853 | $166,281 |
| Other Non Current Assets | $3,783 | $3,783 | $3,783 | $3,783 |
| Non Current Prepaid Assets | $712,055 | $1,478,721 | $0 | - |
| Current Assets | $4,824,978 | $4,650,263 | $28,739 | $69,663 |
| Other Current Assets | $106,542 | $114,086 | $261 | $5,232 |
| Prepaid Assets | $766,667 | $766,667 | $0 | - |
| Inventory | $159,790 | $0 | - | - |
| Receivables | $2,637 | $0 | - | - |
| Accounts Receivable | $2,637 | $0 | - | - |
| Cash Cash Equivalents And Short Term Investments | $3,789,342 | $3,769,510 | $28,478 | $64,431 |
| Cash And Cash Equivalents | $3,789,342 | $3,769,510 | $28,478 | $64,431 |
| Cash Financial | $3,789,342 | $3,769,510 | $28,478 | $64,431 |
| Debt | ||||
| Net Debt | $1,508,726 | - | $2,100,473 | $1,667,808 |
| Total Debt | $5,319,315 | $217,761 | $2,248,493 | $1,898,184 |
| Long Term Debt And Capital Lease Obligation | $0 | $21,247 | $178,041 | $119,544 |
| Current Debt And Capital Lease Obligation | $5,319,315 | $196,514 | $2,070,452 | $1,778,640 |
| Current Debt | $5,298,068 | $146,432 | $2,022,239 | $1,732,239 |
| Other Current Borrowings | $5,298,068 | - | $1,638,760 | $1,638,760 |
| Long Term Debt | - | - | $106,712 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $7,395,882 | $2,030,401 | $5,949,946 | $7,380,028 |
| Total Non Current Liabilities Net Minority Interest | $0 | $21,247 | $178,041 | $119,544 |
| Current Liabilities | $7,395,882 | $2,009,154 | $5,771,905 | $7,260,484 |
| Current Deferred Liabilities | $735 | $0 | - | - |
| Current Notes Payable | $0 | $146,432 | $383,479 | $93,479 |
| Payables And Accrued Expenses | $678,475 | $397,547 | $634,014 | $576,467 |
| Interest Payable | $39,829 | $1,064 | $88,000 | $49,730 |
| Payables | $131,130 | $278,676 | $189,495 | $187,032 |
| Accounts Payable | $131,130 | $278,676 | $189,495 | $187,032 |
| Other Non Current Liabilities | - | - | $-2 | - |
| Other Current Liabilities | - | - | $1,505,398 | $710,599 |
| Equity | ||||
| Common Stock Equity | $-1,831,852 | $4,172,008 | $-5,801,354 | $-7,144,084 |
| Total Equity Gross Minority Interest | $-1,831,852 | $4,172,008 | $-5,801,354 | $-7,144,084 |
| Stockholders Equity | $-1,831,852 | $4,172,008 | $-5,801,354 | $-7,144,084 |
| Retained Earnings | $-34,667,026 | $-26,022,129 | $-23,582,504 | $-18,798,815 |
| Other | ||||
| Ordinary Shares Number | $34,446,455 | $33,103,860 | - | - |
| Share Issued | $34,446,455 | $33,103,860 | - | - |
| Tangible Book Value | $-1,831,852 | $4,172,008 | $-5,801,354 | $-7,144,084 |
| Invested Capital | $3,466,216 | $4,318,440 | $-3,672,403 | $-5,411,845 |
| Working Capital | $-2,570,904 | $2,641,109 | $-5,743,166 | $-7,190,821 |
| Capital Lease Obligations | $21,247 | $71,329 | $119,542 | $165,945 |
| Total Capitalization | $-1,831,852 | $4,172,008 | $-5,694,642 | $-7,144,084 |
| Additional Paid In Capital | $32,831,730 | $30,190,827 | $17,778,498 | $11,652,094 |
| Capital Stock | $3,444 | $3,310 | $2,652 | $2,637 |
| Common Stock | $3,444 | $3,310 | $2,652 | $2,637 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $0 | $21,247 | $71,329 | $119,544 |
| Current Deferred Revenue | $735 | $0 | - | - |
| Current Capital Lease Obligation | $21,247 | $50,082 | $48,213 | $46,401 |
| Pensionand Other Post Retirement Benefit Plans Current | $1,397,357 | $1,415,093 | $1,562,041 | $4,194,778 |
| Current Accrued Expenses | $547,345 | $118,871 | $444,519 | $389,435 |
| Net PPE | $23,214 | $69,642 | $116,070 | $162,498 |
| Accumulated Depreciation | $-212,795 | $-166,367 | $-119,939 | $-73,511 |
| Gross PPE | $236,009 | $236,009 | $236,009 | $236,009 |
| Buildings And Improvements | $236,009 | $236,009 | $236,009 | $236,009 |
| Properties | $0 | $0 | $0 | $0 |
| Other Properties | - | - | - | - |
Fetched: 2026-06-23
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-5,413,736 | $-3,911,004 | $-480,953 | $-1,248,504 |
| Operating Activities | ||||
| Operating Cash Flow | $-5,413,736 | $-3,911,004 | $-480,953 | $-1,248,504 |
| Cash Flow From Continuing Operating Activities | $-5,413,736 | $-3,911,004 | $-480,953 | $-1,248,504 |
| Operating Gains Losses | - | $-804,466 | $739,195 | $784,896 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $0 | $9,875,213 | $55,000 | $0 |
| Financing Cash Flow | $5,433,568 | $7,652,036 | $445,000 | $982,333 |
| Cash Flow From Continuing Financing Activities | $5,433,568 | $7,652,036 | $445,000 | $982,333 |
| Net Common Stock Issuance | $0 | $9,875,213 | $55,000 | $0 |
| Common Stock Issuance | $0 | $9,875,213 | $55,000 | $0 |
| Net Other Financing Charges | - | - | - | - |
| Other | ||||
| Repayment Of Debt | $-146,432 | $-2,361,677 | $0 | - |
| Issuance Of Debt | $5,580,000 | $138,500 | $390,000 | $982,333 |
| Interest Paid Supplemental Data | $38,426 | $147,776 | $28,128 | $81,500 |
| End Cash Position | $3,789,342 | $3,769,510 | $28,478 | $64,431 |
| Beginning Cash Position | $3,769,510 | $28,478 | $64,431 | $330,602 |
| Changes In Cash | $19,832 | $3,741,032 | $-35,953 | $-266,171 |
| Net Issuance Payments Of Debt | $5,433,568 | $-2,223,177 | $390,000 | $982,333 |
| Net Long Term Debt Issuance | $5,433,568 | $-2,223,177 | $390,000 | $982,333 |
| Long Term Debt Payments | $-146,432 | $-2,361,677 | $0 | - |
| Long Term Debt Issuance | $5,580,000 | $138,500 | $390,000 | $982,333 |
| Change In Working Capital | $105,390 | $-2,565,721 | $2,348,250 | $1,548,903 |
| Change In Other Working Capital | $735 | - | - | - |
| Change In Other Current Assets | $3,890 | $-1,785 | $25 | $58,122 |
| Change In Payables And Accrued Expense | $263,192 | $-150,110 | $2,343,254 | $1,490,781 |
| Change In Accrued Expense | $21,029 | $-580 | $2,178,373 | $1,547,060 |
| Change In Interest Payable | $38,765 | $46,368 | $38,270 | $43,128 |
| Change In Payable | $242,163 | $-149,530 | $164,881 | $-56,279 |
| Change In Account Payable | $242,163 | $-149,530 | $164,881 | $-56,279 |
| Change In Prepaid Assets | $0 | $-2,413,826 | $4,971 | - |
| Change In Inventory | $-159,790 | $0 | - | - |
| Change In Receivables | $-2,637 | $0 | - | - |
| Changes In Account Receivables | $-2,637 | $0 | - | - |
| Other Non Cash Items | $707,255 | $57,900 | $16,712 | $558,026 |
| Stock Based Compensation | $2,418,516 | $1,840,908 | $1,198,579 | $817,251 |
| Net Income From Continuing Operations | $-8,644,897 | $-2,439,625 | $-4,783,689 | $-4,957,580 |
| Income Tax Paid Supplemental Data | - | $0 | $0 | $0 |
| Gain Loss On Investment Securities | - | $53,257 | $-148,751 | $-262,514 |
| Net Short Term Debt Issuance | - | - | $390,000 | $0 |
| Short Term Debt Issuance | - | - | $390,000 | $0 |
| Proceeds From Stock Option Exercised | - | - | - | - |
| Short Term Debt Payments | - | - | - | - |
Fetched: 2026-06-23